Trichodysplasia spinulosa (TS) is a rare dermatologic complication associated with the immunosuppressive therapy used in solid organ transplantation. The distinctive clinical manifestation of this condition is spiny follicular papules on the face, ears, extremities, and trunk. Histopathologically, abnormally maturing hair follicles with hyperkeratotic material are noted. The condition is produced by the trichodysplasia spinulosa-associated polyomavirus. Treatment of this condition in the past has entailed a reduction in immunosuppression, topical agents such as cidofovir or retinoids, or oral valganciclovir. Herein, we report a case of generalized TS treated successfully with leflunomide.

No abstract

BACKGROUND Cognitive impairment is not uncommon among older individuals but is often underdiagnosed in the primary care settings. Our objective is to identify the prevalence of varying degrees of cognitive impairment in older adults in urban primary care clinics. METHODS This cross-sectional study was undertaken from May to July 2019. The Montreal Cognitive Assessment (MoCA) was administered to participants 65-year and older who were seen during a routine visit to our primary care clinic. The participants were recruited on a sequential basis. The primary outcomes of the study were the MoCA scores, and the level of cognitive impairment, if any, indicated by the scores. RESULTS Out of the 133 participants, 46 (34.6%) scored below the cut-off of 23 out of 30, indicating certain level of cognitive impairment. The mean MoCA score was 23.24. The average age was 75.19 years. Average years of education was 12.6. In our cohort, higher MoCA scores were associated with increased years of education. MoCA scores were not inversely correlated with age. Language proficiency in the MoCA test version administered had significant impact on the MoCA scores. CONCLUSIONS A relatively high prevalence of cognitive impairment was found in our cohort. Further study is required to accurately assess the prevalence of cognitive impairment in general population. However, the findings attest the value of routine screening for cognitive impairment in primary care settings and warrant routine screening of older individuals to help in early detection of mild cognitive impairment.